Obstructive Sleep Apnea (OSA) accounts for millions of people not getting adequate or restful sleep and result in loss of productivity, car accidents, and is recognized as a co-morbidity of COPD and other diseases. Snoring, a typical symptom of OSA is also a disruption to a sleeping partner with potentially similar clinical manifestations as the afflicted person themselves. One of the existing approved medical treatment options for snoring and mild to moderate OSA include oral appliances. Oral appliances offer many advantages over the traditional positive airway pressure (PAP) type of devices, including no noise, less physically annoying (to many), and ease of portability. However, oral appliances also lack the capabilities necessary for monitoring compliance and effectiveness that are needed to fulfill regulatory requirements and conduct population-based effectiveness research. The proposed work will design, develop and prototype a new system that will be incorporated into multiple oral appliances and will specifically monitor compliance and effectiveness. The phase I will successfully design, develop, and prototype a system that can be incorporated into the oral appliances. A phase II will develop and implement extended clinical protocols for testing and evaluating the clinical compliance and effectiveness of various oral appliances.

Public Health Relevance

Oral appliances are becoming a more accepted and utilized treatment for Obstructive Sleep Apnea, however, they lack the capabilities necessary for monitoring compliance and effectiveness that are needed to fulfill regulatory requirements and conduct population-based effectiveness research. This proposed work will design, develop and prototype a new system that will be incorporated into multiple oral appliances and will specifically monitor compliance and effectiveness in a non-obtrusive and without any significant increase in patient burden.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43HL120421-01
Application #
8592503
Study Section
Special Emphasis Panel (ZRG1-BBBP-V (11))
Program Officer
Twery, Michael
Project Start
2013-09-01
Project End
2015-02-28
Budget Start
2013-09-01
Budget End
2015-02-28
Support Year
1
Fiscal Year
2013
Total Cost
$210,951
Indirect Cost
Name
Cleveland Medical Devices, Inc.
Department
Type
DUNS #
557510625
City
Cleveland
State
OH
Country
United States
Zip Code
44103